Saini K, Somara S, Ko H, Thatai P, Quintana A, Wallen Z
Front Oncol. 2024; 14:1473706.
PMID: 39439946
PMC: 11493772.
DOI: 10.3389/fonc.2024.1473706.
von der Grun J, Broglie M, Guckenberger M, Balermpas P
Cancer Immunol Immunother. 2024; 73(11):222.
PMID: 39235625
PMC: 11377404.
DOI: 10.1007/s00262-024-03810-6.
Rubenich D, Domagalski J, Gentil G, Eichberger J, Fiedler M, Weber F
J Extracell Vesicles. 2024; 13(7):e12480.
PMID: 38978304
PMC: 11231043.
DOI: 10.1002/jev2.12480.
Kasahara K, Kono T, Sato Y, Ueno M, So H, Fuse Y
Front Oncol. 2024; 14:1378762.
PMID: 38549928
PMC: 10973154.
DOI: 10.3389/fonc.2024.1378762.
Constantin M, Chifiriuc M, Mihaescu G, Vrancianu C, Dobre E, Cristian R
Front Oncol. 2024; 13:1273516.
PMID: 38179168
PMC: 10765588.
DOI: 10.3389/fonc.2023.1273516.
The Prognosis Performance of a Neutrophil- and Lymphocyte-Associated Gene Mutation Score in a Head and Neck Cancer Cohort.
Yeh T, Wang H, Cho S, Wu C, Hsieh T, Huang C
Biomedicines. 2023; 11(12).
PMID: 38137334
PMC: 10741104.
DOI: 10.3390/biomedicines11123113.
Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma.
Zhou J, Wei S, Guo X, Huang Y, Zhang Y, Hong Y
BMC Cancer. 2023; 23(1):1247.
PMID: 38110870
PMC: 10726578.
DOI: 10.1186/s12885-023-11752-y.
The Prognostic Value of Platelet-Lymphocyte Ratio, Neutrophil-Lymphocyte Ratio, and Monocyte-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma (HNSCC)-A Retrospective Single Center Study and a Literature Review.
Mirestean C, Stan M, Iancu R, Iancu D, Badulescu F
Diagnostics (Basel). 2023; 13(22).
PMID: 37998532
PMC: 10670617.
DOI: 10.3390/diagnostics13223396.
Fixing the Leaky Pipe: How to Improve the Uptake of Patient-Reported Outcomes-Based Prognostic and Predictive Models in Cancer Clinical Practice.
Spencer K, Absolom K, Allsop M, Relton S, Pearce J, Liao K
JCO Clin Cancer Inform. 2023; 7:e2300070.
PMID: 37976441
PMC: 10681558.
DOI: 10.1200/CCI.23.00070.
Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastatic head and neck squamous cell carcinoma predominantly receiving immune checkpoint inhibitors.
Xue L, Tang W, Zhou J, Xue J, Li Q, Ge X
Front Oncol. 2023; 13:1276009.
PMID: 37936609
PMC: 10627168.
DOI: 10.3389/fonc.2023.1276009.
Preoperative lymphocyte count, neutrophil to lymphocyte and platelet to lymphocyte ratio predict the recurrence with progression and cancerization in vocal fold lesions-retrospective study.
Rzepakowska A, Pietruszewska W, Zurek M, Molga-Magusiak M, Leszczynski M, Niemczyk K
PeerJ. 2023; 11:e15642.
PMID: 37744219
PMC: 10517654.
DOI: 10.7717/peerj.15642.
A predictive survival model for patients with stage IV oropharyngeal squamous cell carcinoma treated with chemoradiation.
Yeh P, Chang C, Liao L, Wu C, Hsieh C, Shueng P
Eur Arch Otorhinolaryngol. 2023; 281(1):369-377.
PMID: 37594545
DOI: 10.1007/s00405-023-08187-3.
Immune Checkpoint Inhibitors, Small-Molecule Immunotherapies and the Emerging Role of Neutrophil Extracellular Traps in Therapeutic Strategies for Head and Neck Cancer.
OMeara C, Jafri Z, Khachigian L
Int J Mol Sci. 2023; 24(14).
PMID: 37511453
PMC: 10380483.
DOI: 10.3390/ijms241411695.
Biomarkers for Predicting Anti-Programmed Cell Death-1 Antibody Treatment Effects in Head and Neck Cancer.
Tanaka K, Hirakawa H, Suzuki M, Higa T, Agena S, Hasegawa N
Curr Oncol. 2023; 30(6):5409-5424.
PMID: 37366893
PMC: 10297315.
DOI: 10.3390/curroncol30060410.
Neutrophil-to-lymphocyte ratio as a predictor of surgical outcomes in head and neck cancer.
Kao D, Ferrandino R, Roof S, Marshall D, Khan M, Chai R
Head Neck. 2023; 45(8):1903-1912.
PMID: 37204760
PMC: 10349925.
DOI: 10.1002/hed.27402.
The colon inflammatory index score can predict the survival outcome after resection of colorectal cancer: a retrospective multicentre study.
Akiyama T, Miyamoto Y, Matsuda A, Tokunaga R, Ogawa K, Iwatsuki M
J Cancer Res Clin Oncol. 2023; 149(10):7887-7894.
PMID: 37058251
DOI: 10.1007/s00432-023-04770-7.
Review of biomarkers for response to immunotherapy in HNSCC microenvironment.
Chen S, Yang Y, He S, Lian M, Wang R, Fang J
Front Oncol. 2023; 13:1037884.
PMID: 36860322
PMC: 9968921.
DOI: 10.3389/fonc.2023.1037884.
Neutrophil to Lymphocyte Ratio in Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Rodrigo J, Sanchez-Canteli M, Triantafyllou A, de Bree R, Makitie A, Franchi A
Cancers (Basel). 2023; 15(3).
PMID: 36765760
PMC: 9913392.
DOI: 10.3390/cancers15030802.
Evaluation of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Mean Platelet Volume in Patients with Branchial Cleft Cyst.
Durgut O, Gokgun O, Gencay S
Indian J Otolaryngol Head Neck Surg. 2023; 74(Suppl 3):5465-5468.
PMID: 36742740
PMC: 9895673.
DOI: 10.1007/s12070-021-02789-1.
Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma.
Justesen M, Jakobsen K, Bendtsen S, Garset-Zamani M, Mordhorst C, Fenger Carlander A
Viruses. 2023; 15(1).
PMID: 36680237
PMC: 9863220.
DOI: 10.3390/v15010198.
